Reading the NeoVax Headlines: What a Phase 1 Trial Really ShowsBy Angus MacDonaldOctober 16, 2026 A phase 1 Nature Medicine trial found a personalised NeoVax vaccine with nivolumab feasible and acceptably safe in platinum-sensitive ovarian cancer.
